Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX) is a Healthcare stock tracked by StreetAlpha. EWTX reports earnings on Thu, Nov 5, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in EWTX, 100% of them bullish and 0% bearish. In the past 30 days there were 3 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 21 | HC Wainwright & Co. | Target raised | Buy | — |
| Aug 20 | JP Morgan | Maintained | Buy | — |
| Aug 11 | Goldman Sachs | Target raised | Hold | — |
| Jul 20 | Evercore ISI Group | Maintained | Buy | — |
| Jul 9 | Oppenheimer | Initiated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EWTX is in one of them and how their past EWTX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered EWTX in an article yet. Here's the latest on the wider market.